Primary study · included by 1 review

Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study.

Ilera 2023 · Ilera Verónica, Califano Inés, Cavallo Andrea, et al. · Endocrine · 2023

Included by

Reassessing Radioactive Iodine Use After Thyroidectomy in Low-Risk Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.

Non-Cochrane · intervention · 2026 · cited as Ilera 2023 · Table 1; Fig. 3-8

Outcome this study informs	Pooled effect	Evidence	Certainty
Indeterminate response to treatment Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)	OR 0.91 [0.46, 1.80]	3 studies · 1104 participants	GRADE not reported
Structurally incomplete response to treatment Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)	OR 1.49 [0.51, 4.36]	3 studies · 1104 participants	GRADE not reported
Excellent response to treatment Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)	OR 1.00 [0.52, 1.92]	3 studies · 1104 participants	GRADE not reported
Biochemically incomplete response to treatment Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)	OR 0.54 [0.10, 2.86]	3 studies · 1104 participants	GRADE not reported

1 including review in total.